Stephen F. Betz

Companies

• Crinetics PharmaceuticalsChief Scientific Officer Oct 19, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Crinetics Pharmaceuticals0 shares²Sep 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 1, 2026Returned to company 79,650 shares at $85.00 of Crinetics Pharmaceuticals²
• Sep 1, 2026Returned to company 58,286 shares at $85.00 of Crinetics Pharmaceuticals²
• Mar 16, 2026Sold 4,241 shares at $37.77 of Crinetics Pharmaceuticals³
• Mar 16, 2026Sold 6,371 shares at $37.11 of Crinetics Pharmaceuticals³
• Feb 23, 2026Granted 30,000 shares of Crinetics Pharmaceuticals⁴
• Dec 26, 2025Exercised options 18,000 shares at $1.91 of Crinetics Pharmaceuticals⁵
• Jun 12, 2025Sold 97,483 shares at $32.23 of Crinetics Pharmaceuticals⁶
• Jun 12, 2025Exercised options 16,645 shares at $9.28 of Crinetics Pharmaceuticals⁶
• Jun 12, 2025Exercised options 71,525 shares at $1.91 of Crinetics Pharmaceuticals⁶
• Mar 19, 2025Sold 291 shares at $34.83 of Crinetics Pharmaceuticals⁷
• Mar 19, 2025Sold 5,479 shares at $34.17 of Crinetics Pharmaceuticals⁷
• Feb 20, 2025Granted 43,000 shares of Crinetics Pharmaceuticals⁸
• Dec 16, 2024Exercised options 2,331 shares at $1.91 of Crinetics Pharmaceuticals⁹
• Nov 20, 2024Other 451 shares at $14.98 of Crinetics Pharmaceuticals¹⁰
• Sep 10, 2024Sold 1,035 shares at $51.50 of Crinetics Pharmaceuticals¹¹
• Aug 26, 2024Sold 3,000 shares at $53.19 of Crinetics Pharmaceuticals¹²
• Aug 12, 2024Sold 3,000 shares at $47.68 of Crinetics Pharmaceuticals¹³
• Jul 25, 2024Sold 3,000 shares at $53.43 of Crinetics Pharmaceuticals¹⁴
• Jul 10, 2024Sold 3,000 shares at $48.55 of Crinetics Pharmaceuticals¹⁵
• Jun 25, 2024Sold 3,000 shares at $45.37 of Crinetics Pharmaceuticals¹⁶
• Jun 10, 2024Sold 3,000 shares at $43.86 of Crinetics Pharmaceuticals¹⁷
• May 28, 2024Sold 3,000 shares at $47.49 of Crinetics Pharmaceuticals¹⁸
• May 10, 2024Sold 3,000 shares at $49.43 of Crinetics Pharmaceuticals¹⁹
• Mar 18, 2024Shares withheld for tax 3,655 shares at $38.14 of Crinetics Pharmaceuticals²⁰
• Mar 4, 2024Granted 23,000 shares of Crinetics Pharmaceuticals²¹